News Snapshot:
mediabest science Health officials said an investigation by BioNTech found no safety issues in the batch with packaging defects for some vials, as well as in a separate, unused batch of the vaccine. Hong Kong will resume administering the coronavirus vaccine developed by Pfizer and BioNTech on Monday following a 12-day suspension over packaging defects detected in one batch, officials said. An additional 300,000 doses of the vaccine are expected to arrive on Friday, Civil Service Secretary Patrick Nip said Thursday. Health officials said an investigation by BioNTech found no safety issues in the batch with packaging defects for some...